Von Willebrand Factor: Clinical Features of Inherited and Acquired Disorders

This publication has 16 references indexed in Scilit:

• Calpain proteolysis of von Willebrand factor enhances its binding to platelet membrane glycoprotein IIb/IIIa: an explanation for platelet aggregation in thrombotic thrombocytopenic purpura
  British Journal of Haematology, 1990
• Increased platelet sensitivity to ristocetin is predicted by the binding characteristics of a GPIb/IX determinant
  British Journal of Haematology, 1990
• Bleeding time, blood groups and von Willebrand factor
  British Journal of Haematology, 1989
• Fetal and neonatal von Willebrand factor (vWF) is unusually large and similar to the vWF in patients with thrombotic thrombocytopenic purpura
  British Journal of Haematology, 1989
• The effect of desamino-D-arginine vasopressin (DDAVP) and naloxone infusions on factor VIII and possible endothelial cell (EC) related activities
  British Journal of Haematology, 1984
• ACQUIRED IMMUNODEFICIENCY SYNDROME AND OTHER POSSIBLE IMMUNOLOGICAL DISORDERS IN EUROPEAN HAEMOPHILIACS
  The Lancet, 1984
• Pseudo-von Willebrand's Disease
  New England Journal of Medicine, 1982
• Factor VIII and Fibrinolytic Response to Deamino‐8‐d‐Argenine Vasopressin in Normal Subjects and Dissociate Response in Some Patients with Haemophilia and von Willebrand's Disease
  British Journal of Haematology, 1980
• High potency factor VIII concentrate: More effective than cryoprecipitate in a patient with Von Willebrand's disease and inhibitor
  Thrombosis Research, 1979
• The Factor VIII Abnormality in Severe von Willebrand's Disease
  New England Journal of Medicine, 1979